Literature DB >> 29422691

Optimal stratification in outcome prediction using baseline information.

Florence H Yong1, Lu Tian2, Sheng Yu3, Tianxi Cai4, L J Wei4.   

Abstract

A common practice in predictive medicine is to use current study data to construct a stratification procedure, which groups subjects according to baseline information and forms stratum-specific prevention or intervention strategies. A desirable stratification scheme would not only have small intra-stratum variation but also have a clinically meaningful discriminatory capability. We show how to obtain optimal stratification rules with such desirable properties from fitting a set of regression models relating the outcome to baseline covariates and creating scoring systems for predicting potential outcomes. We propose that all available optimal stratifications be evaluated with an independent dataset to select a final stratification. Lastly, we obtain inferential results for this selected stratification scheme with a holdout dataset. When only one study of moderate size is available, we combine the first two steps via crossvalidation. Extensive simulation studies are used to compare the proposed stratification strategy with alternatives. We illustrate the new proposal using an AIDS clinical trial for binary outcomes and a cardiovascular clinical study for censored event time outcomes.

Entities:  

Keywords:  Cox regression model; Crossvalidation; Dynamic programming; Prediction score; Stratified medicine

Year:  2016        PMID: 29422691      PMCID: PMC5793688          DOI: 10.1093/biomet/asw049

Source DB:  PubMed          Journal:  Biometrika        ISSN: 0006-3444            Impact factor:   2.445


  11 in total

1.  A simulation study of predictive ability measures in a survival model II: explained randomness and predictive accuracy.

Authors:  B Choodari-Oskooei; P Royston; Mahesh K B Parmar
Journal:  Stat Med       Date:  2012-07-05       Impact factor: 2.373

2.  Predicting the restricted mean event time with the subject's baseline covariates in survival analysis.

Authors:  Lu Tian; Lihui Zhao; L J Wei
Journal:  Biostatistics       Date:  2013-11-29       Impact factor: 5.899

3.  A simulation study of predictive ability measures in a survival model I: explained variation measures.

Authors:  Babak Choodari-Oskooei; Patrick Royston; Mahesh K B Parmar
Journal:  Stat Med       Date:  2011-04-26       Impact factor: 2.373

4.  The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt.

Authors:  Patrick Royston; Mahesh K B Parmar
Journal:  Stat Med       Date:  2011-05-25       Impact factor: 2.373

5.  Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.

Authors:  Scott D Solomon; Madeline M Rice; Kathleen A Jablonski; Powell Jose; Michael Domanski; Marc Sabatine; Bernard J Gersh; Jean Rouleau; Marc A Pfeffer; Eugene Braunwald
Journal:  Circulation       Date:  2006-06-26       Impact factor: 29.690

6.  EFFECTIVELY SELECTING A TARGET POPULATION FOR A FUTURE COMPARATIVE STUDY.

Authors:  Lihui Zhao; Lu Tian; Tianxi Cai; Brian Claggett; L J Wei
Journal:  J Am Stat Assoc       Date:  2013-01-01       Impact factor: 5.033

7.  A predictive enrichment procedure to identify potential responders to a new therapy for randomized, comparative controlled clinical studies.

Authors:  Junlong Li; Lihui Zhao; Lu Tian; Tianxi Cai; Brian Claggett; Andrea Callegaro; Benjamin Dizier; Bart Spiessens; Fernando Ulloa-Montoya; Lee-Jen Wei
Journal:  Biometrics       Date:  2015-12-21       Impact factor: 2.571

8.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

9.  Angiotensin-converting-enzyme inhibition in stable coronary artery disease.

Authors:  Eugene Braunwald; Michael J Domanski; Sarah E Fowler; Nancy L Geller; Bernard J Gersh; Judith Hsia; Marc A Pfeffer; Madeline M Rice; Yves D Rosenberg; Jean L Rouleau
Journal:  N Engl J Med       Date:  2004-11-07       Impact factor: 91.245

10.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.